TransMedics (TMDX) · page 319 of 342
The slide uses expert testimony to frame TransMedics as an overpriced incumbent being disrupted by a cheaper, established European technique (NRP).
Research note · villain_critique · name_villain · dense density
Slide locked Sign in to view
Slide schematic 3/3
list 1/1 paragraph 1/1 source-note 1/1
Components 3
bullet paragraph source-note
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1